Peptides DB
Research-centric peptide and protocol reference hub
Study 45 of 45VIP (Vasoactive Intestinal Polypeptide) literaturebiorxiv-preprint · Observational · Preclinical2026

Longitudinal Imaging in a Mouse Model of Focal Cortical Dysplasia Reveals Lesion Expansion and Loss of Pre-Discharge Neuronal Recruitment

Focal cortical dysplasia type II lesions are dynamic and change over time, particularly in relation to seizure activity, which may impact treatment timing and strategies.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the vip (vasoactive intestinal polypeptide) corpus
9
Preclinical
29
Observational · this one
1
Open-label
2
Randomised
4
Reviews

Summary and findings

This study investigated the dynamics of focal cortical dysplasia type II (FCD II) in a mouse model using in vivo imaging techniques. The researchers observed progressive lesion expansion and changes in neuronal activity over time. No specific therapeutic claims were made.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.Preclinical2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

ABSTRACT Objective: Focal cortical dysplasia type II (FCD II) is a leading cause of drug-resistant focal epilepsy, yet how its lesional circuits behave and change over time in vivo has not been directly observed. <h4>Methods:</h4> We used a mouse model of FCD II carrying the patient-derived gain-of-function mTORp.L2427P variant introduced by in utero electroporation. Through a chronic cranial window over the lesion, we performed repeated in vivo two-photon calcium imaging of identified dysmorphic neurons, pyramidal cells, and VIP interneurons at defined time points, combined with video-EEG monitoring, to determine seizure status and relate cellular activity to interictal discharges. <h4>Results:</h4> The lesion was not static in adulthood. Dysplastic cortex expanded progressively. This expansion occurred without the tenascin R/C accumulation reported in human FCD II, and was partly explained by continued somatic growth of dysmorphic neurons. Dysmorphic neurons were generally hypoactive; in seizing mice, both dysmorphic and pyramidal cell activity progressively declined, whereas VIP interneuron activity increased slightly in non-seizing animals. In non-seizing lesional cortex, neurons were reliably recruited immediately before interictal discharges. By late disease stages, pre-discharge recruitment had weakened to the point that lesional layer 2/3 neurons were no more active before discharges than expected by chance. Significance: These findings recast FCD II as a lesion that continues to remodel structurally and functionally throughout adulthood, and does so most markedly in animals with seizures. Growth, a cell-type-specific shift in spontaneous activity, and a progressive loss of the lesion's temporal lead over interictal discharges together suggest that FCD II is a dynamically evolving lesion whose relationship to epileptiform activity changes over time. If the lesion progressively loses its generative role, the window in which removing it can arrest the disease is finite, consistent with clinical evidence favoring earlier surgery.

Background

Focal cortical dysplasia type II (FCD II) is a significant cause of drug-resistant focal epilepsy, and understanding its lesional circuits is crucial for developing effective interventions. Prior research has indicated that FCD II lesions may undergo structural and functional changes, but direct longitudinal observations in vivo have been lacking. This study aims to fill that gap by examining the dynamics of FCD II lesions over time using advanced imaging techniques.

Methods

The study employed a mouse model of FCD II with the mTORp.L2427P variant introduced via in utero electroporation. Repeated in vivo two-photon calcium imaging and video-EEG monitoring were conducted to assess neuronal activity and seizure status at defined time points. The study focused on dysmorphic neurons, pyramidal cells, and VIP interneurons, with no specific sample size reported.

Results

The primary observation was that the dysplastic cortex expanded progressively in adulthood. Dysmorphic neurons exhibited hypoactivity, and in seizing mice, both dysmorphic and pyramidal cell activity progressively declined. VIP interneuron activity showed a slight increase in non-seizing animals. By late disease stages, the recruitment of lesional layer 2/3 neurons before interictal discharges weakened significantly.

Interpretation

These findings suggest that FCD II lesions are not static but rather undergo continuous remodeling, particularly in the presence of seizures. The observed changes in neuronal activity and recruitment patterns indicate that the relationship between the lesion and epileptiform activity evolves over time. However, the small sample size and reliance on a mouse model limit the applicability of these results to human cases.

Key findings

  • Dysplastic cortex expanded progressively in adulthood.
  • Dysmorphic neurons were generally hypoactive; in seizing mice, both dysmorphic and pyramidal cell activity progressively declined.
  • VIP interneuron activity increased slightly in non-seizing animals.
  • By late disease stages, pre-discharge recruitment of lesional layer 2/3 neurons weakened to the point that it was no more active before discharges than expected by chance.

Limitations

  • Based on a mouse model, which may not fully replicate human conditions.
  • No specific sample size reported.
  • Findings may not be generalizable to human patients with FCD II.

Elsewhere in the VIP (Vasoactive Intestinal Polypeptide) corpus

CCortex-wide imaging in naturally behaving mice with 1-gram wireless mesoscopes.Nature · 2026AnimalCCalcium-Binding Protein Expression Cannot Serve as a General Classifier for GABAergic Neurons in the Macaque Cortex.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026 · up to 50% of neurons expressing CBPs are likely not GABAergicAnimalCATR-FTIR spectral fingerprinting and Chemometric classification of Labisia pumila varieties with exploratory screening of herbal products.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2026 · R²Y = 0.894, Q² = 0.894 for the final PLS-DA model.In vitroBIon Channels and Morphology Drive Widespread Resonance in Human Cortical Interneuronsbiorxiv-preprint · 2026 · Not reported in abstract.HumanDClinical update: Assessment and management of Helicobacter pylori infection.BMJ (Clinical research ed.) · 2026reviewCGlycine transporter 1 inhibitor, bitopertin, changes excitatory and inhibitory network connectivity in mouse medial prefrontal cortex.Neuropharmacology · 2026 · Not reported in abstract.Animal